查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233128

放射腫瘤學市場規模、份額和趨勢分析報告：按類型（外束放療、內束放療）、技術、應用、地區、細分趨勢，2023-2030 年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

放射腫瘤學市場增長和趨勢

Grand View Research, Inc. 的最新報告顯示，2023 年至 2030 年全球放射腫瘤學市場的複合年增長率將達到 12.3%，到 2030 年將達到 211.4 億，預計將達到美國美元。

市場增長受全球癌症負擔不斷增加、人口老齡化以及政府和私營組織實施的支持性報銷計劃等因素推動。 此外，放射治療領域不斷創新和進步為市場增長提供了機會。

世界正在見證癌症患者的增加，這是推動放射腫瘤學市場增長的主要因素。 例如，根據 Globocan 的數據，2020 年將有超過 2000 萬人被診斷出患有癌症，1000 萬人將死於癌症。 此外，由於免疫力下降和合併症，老齡化社會增加了患癌症的風險，從而增加了老年人口，進一步推動了市場增長。 例如，據世界衛生組織估計，2020年全球老年人口約為10億，預計2050年將達到21億。

為開發新型放射治療技術和多學科治療方法而開展的廣泛研究活動有望​​提高癌症存活率和改善預後。 例如，2022 年 12 月，Elekta Unity 展示了 MR-Linac 在胰腺腫瘤中的應用，首例患者接受了新的先進放射治療運動管理。

同樣，2020 年 6 月，Isolei 與UC Physics就治療頸部和頭部癌症達成了一項研究協議。 兩家公司計劃在手術切除後評估 Keytruda 和銫 131 的療效。 在癌症治療中使用此類醫用同位素有可能通過瞭解疾病的複雜性和患者需求來擴大市場機會，促進新型靶向特異性放射治療系統的研究和開發。我有。

此外，放療的支持性報銷和監管政策也有望推動放療市場的增長。 例如，2021 年 7 月，醫療保險和醫療補助服務中心 (CMS) 為癌症診斷和放射治療服務開發了一種新的放射腫瘤學支付模式 (RO-APM)。 這可以提高患者護理質量並減少每年的醫療保險支出。

放射腫瘤學市場報告要點

  • 按類型劃分，外照射放射治療 (EBRT) 領域由於技術的快速進步而被引入以治療各種類型的癌症，到 2022 年將佔據放射腫瘤學市場 64.53% 的份額。
  • 就技術而言，由於治療需求未得到滿足的國家越來越多地使用技術先進的調強放療 (IMRT)，調強放療 (IMRT) 細分市場將在 2022 年佔據市場主導地位。底部。 然而，近距離放射治療估計是預測期內增長最快的部分。
  • 到 2022 年，EBRT 細分市場將在應用領域佔據最高的市場份額。 此外，EBRT 部分預計將在預測期內保持其主導地位。
  • 北美在 2022 年佔據了全球市場的主導地位，原因包括新癌症患者的增加、醫療保健專業人員對先進放射療法的高度認識以及該地區醫療保健服務的改善等。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 次要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概覽

第 3 章市場變量、趨勢和範圍

  • 市場細分
  • 市場定義
  • 優先關鍵機會
  • 市場動態分析
    • 放療的採用率提高
    • 放射治療的技術進步
    • 癌症患病率上升
    • 不斷上漲的醫療費用
    • 增加放射性藥物的應用
  • 市場製約因素分析
    • 缺乏熟練的放射治療專業人員
    • 輻射基礎設施不足
    • 放療的副作用
  • 商業環境分析
    • SWOT 分析；按因素（政治和法律、經濟和技術）
    • 波特的五力分析

第 4 章放射腫瘤學市場 - 細分分析，按類型，2018-2030（百萬美元）

  • 放射腫瘤學市場：類型變異分析
  • 外部放射治療
    • 電子發射高能直線加速器
    • 緊湊型先進放射治療系統
      • 網絡刀
      • 伽瑪刀
      • 斷層掃瞄療法
    • 質子治療
      • 迴旋加速器
      • 同步加速器
  • 內部放療
    • 近距離放射治療
      • 種子
      • 塗抹器和後裝器
      • 電子近距離放射治療
    • 全身放療
    • 其他

第 5 章放射腫瘤學市場 - 細分分析，按技術，2018-2030 年（百萬美元）

  • 放射腫瘤學市場：技術波動分析
  • 外照射放射治療 (EBRT)
    • 圖像引導放射治療 (IGRT)
    • 調強放射治療 (IMRT)
    • 立體定向放射治療
    • 質子治療
    • 3D 適形放療 (3D-CRT)
    • 容積調製電弧療法 (VMAT)
  • 近距離放射治療
    • 低劑量率 (LDR) 近距離放射治療
    • 高劑量率 (HDR) 近距離放射治療

第 6 章放射腫瘤學市場 - 細分分析，按應用，2018-2030 年（百萬美元）

  • 放射腫瘤學市場：應用差異分析
  • 外照射放射治療 (EBRT)
    • 前列腺癌
    • 乳腺癌
    • 肺癌
    • 頭頸癌
    • 結腸癌
    • 其他
  • 內部放療
    • 前列腺癌
    • 婦科癌症
    • 乳腺癌
    • 宮頸癌
    • 陰莖癌
    • 其他

第 7 章放射腫瘤學市場 - 細分分析，按地區，2018-2030 年（百萬美元）

  • 定義和範圍
  • 北美
    • 北美，SWOT 分析
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 歐洲
    • 歐洲，SWOT 分析
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 其他歐洲
  • 亞太地區
    • 亞太地區，SWOT 分析
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 亞太地區的其他國家/地區
  • 拉丁美洲
    • 拉丁美洲，SWOT 分析
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 其他拉丁語美國
  • 多邊環境協定
    • 中東和非洲，SWOT 分析
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • MEA 的剩餘部分

第八章競爭格局

  • 上市公司
    • 公司市場分析
    • 競爭儀表板分析
    • 戰略框架
  • 私人公司
    • 主要初創企業/技術顛覆者/創新者名單
    • 本地網絡地圖
  • 公司簡介
    • Varian Medical Systems, Inc.（A Part Of Siemens Healthineers）
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Elekta AB
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Accuray Incorporated
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Ion Beam Applications（IBA）.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • BD（Becton, Dickinson And Company）
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Isoray Medical
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Mevion Medical Systems
      • 公司概況
      • 產品基準
      • 戰略舉措
    • Nordion Inc.
      • 公司概況
      • 產品基準
      • 戰略舉措
    • NTP Radioisotopes SOC Ltd.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Curium
      • 公司概況
      • 產品基準
      • 戰略舉措
    • VIEWRAY TECHNOLOGIES, INC.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market is expected to reach USD 21.14 billion by 2030, registering a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • By type, the external beam radiation therapy (EBRT) segment accounted for a 64.53% share of the radiation oncology market in 2022 due to the rapid technological advancement, and increased adoption in the treatment of various types of cancers
  • Based on technology, in 2022 intensity-modulated radiotherapy (IMRT) segment dominated the market due to the increased availability of technologically advanced IMRT's in countries with unmet treatment needs. However, brachytherapy is estimated to be the fastest-growing segment during the forecast period
  • In 2022, EBRT segment held the highest market share in the application space. Moreover, EBRT segment is also anticipated to maintain its dominance during the forecast period
  • North America dominated the global market in 2022 owing to the factors such as the increase in new cancer cases, high awareness among healthcare professionals about advanced radiotherapy, and better healthcare access in the region

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline:
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Definitions
  • 3.3 Key Opportunities Prioritized
  • 3.4 Market Dynamic Analysis
    • 3.4.1 Rising Adoption Of Radiotherapy
    • 3.4.2 Technological Advancements In Radiotherapy
    • 3.4.3 Rising Prevalence Of Cancer
    • 3.4.4 Increase In Healthcare Expenditure
    • 3.4.5 Increasing APPLICATION OF Radiopharmaceuticals
  • 3.5 Market Restraint Analysis
    • 3.5.1 Lack Of Skilled Radiotherapy Professionals
    • 3.5.2 Inadequate Radiation Infrastructure
    • 3.5.3 Adverse Effects Of Radiotherapy
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By Factor (POLITICAL & LEGAL, Economic And Technological)
    • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Radiation Oncology Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Radiation Oncology Market: Type Movement Analysis
  • 4.2 External Beam Radiation Therapy
    • 4.2.1 External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.2.2 Electron-Emitting High Energy Linear Accelerators
      • 4.2.2.1 Electron-Emitting High Energy Linear Accelerators Market, 2018 - 2030 (USD Million)
    • 4.2.3 Compact Advanced Radiotherapy Systems
      • 4.2.3.1 Compact Advanced Radiotherapy Systems Market, 2018 - 2030 (USD Million)
      • 4.2.3.2 Cyberknife
      • 4.2.3.2.1 Cyberknife Market, 2018 - 2030 (USD Million)
      • 4.2.3.3 Gamma Knife
      • 4.2.3.3.1 Gamma Knife Market, 2018 - 2030 (USD Million)
      • 4.2.3.4 Tomotherapy
      • 4.2.3.4.1 Tomotherapy Compact Market, 2018 - 2030 (USD Million)
    • 4.2.4 Proton Therapy
      • 4.2.4.1 Proton Therapy Market, 2018 - 2030 (USD Million)
      • 4.2.4.2 Cyclotron
      • 4.2.4.2.1 Cyclotron Market, 2018 - 2030 (USD Million)
      • 4.2.4.3 Synchrotron
      • 4.2.4.3.1 Synchrotron Market, 2018 - 2030 (USD Million)
  • 4.3 Internal Beam Radiation Therapy
    • 4.3.1 Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.2 Brachytherapy
      • 4.3.2.1 Brachytherapy Market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Seeds
      • 4.3.2.2.1 Seeds Market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Applicators And After-Loaders
      • 4.3.2.3.1 Applicators And After-Loaders Market, 2018 - 2030 (USD Million)
      • 4.3.2.4 Electronic Brachytherapy
      • 4.3.2.4.1 Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
    • 4.3.3 Systemic Beam Radiation Therapy
      • 4.3.3.1 Systemic Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.4 Others
      • 4.3.4.1 Others Market, 2016-2028 (USD Million)

Chapter 5 Radiation Oncology Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Radiation Oncology Market: Technology Movement Analysis
  • 5.2 External Beam Radiation Therapy (EBRT)
    • 5.2.1 EBRT Market, 2018 - 2030 (USD Million)
    • 5.2.2 Image-Guided Radiation Therapy (IGRT)
      • 5.2.2.1 IGRT Market, 2018 - 2030 (USD Million)
    • 5.2.3 Intensity Modulated Radiotherapy (IMRT)
      • 5.2.3.1 IMRT Market, 2018 - 2030 (USD Million)
    • 5.2.4 Stereotactic Radiotherapy
      • 5.2.4.1 Stereotactic Radiotherapy Market, 2018 - 2030 (USD Million)
    • 5.2.5 Proton Beam Therapy
      • 5.2.5.1 Proton Beam Therapy Market, 2018 - 2030 (USD Million)
    • 5.2.6 3D Conformal Radiotherapy (3D-CRT)
      • 5.2.6.1 3D-CRT Market, 2018 - 2030 (USD Million)
    • 5.2.7 Volumetric Modulated Arc Therapy (VMAT)
      • 5.2.7.1 VMAT Market, 2018 - 2030 (USD Million)
  • 5.3 Brachytherapy
    • 5.3.1 Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.2 Low Dose Rate (LDR) Brachytherapy
      • 5.3.2.1 LDR Brachytherapy Market, 2018 - 2030 (USD Million)
    • 5.3.3 High Dose Rate (HDR) Brachytherapy
      • 5.3.3.1 HDR Brachytherapy Market, 2018 - 2030 (USD Million)

Chapter 6 Radiation Oncology Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Radiation Oncology Market: Application Movement Analysis
  • 6.2 External Beam Radiation Therapy (EBRT)
    • 6.2.1 Prostate Cancer
      • 6.2.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.2 Breast Cancer
      • 6.2.2.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.3 Lung Cancer
      • 6.2.3.1 Lung Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.4 Head And Neck Cancer
      • 6.2.4.1 Head And Neck Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.5 Colorectal Cancer
      • 6.2.5.1 Colorectal Cancer Market, 2018 - 2030 (USD Million)
    • 6.2.6 Others
      • 6.2.6.1 Others Market, 2018 - 2030 (USD Million)
  • 6.3 Internal Beam Radiation Therapy
    • 6.3.1 Prostate Cancer
      • 6.3.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.2 Gynecologic Cancer
      • 6.3.2.1 Gynecologic Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.3 Breast Cancer
      • 6.3.3.1 Breast Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.4 Cervical Cancer
      • 6.3.4.1 Cervical Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.5 Penile Cancer
      • 6.3.5.1 Penile Cancer Market, 2018 - 2030 (USD Million)
    • 6.3.6 Others
      • 6.3.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Radiation Oncology Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 North America
    • 7.2.1 North America, SWOT Analysis
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.2.2 Key Country Dynamics
      • 7.2.2.3 Target Disease Prevalence
      • 7.2.2.4 Competitive Scenario
      • 7.2.2.5 Regulatory Framework
      • 7.2.2.6 Reimbursement Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.3.2 Key Country Dynamics
      • 7.2.3.3 Target Disease Prevalence
      • 7.2.3.4 Competitive Scenario
      • 7.2.3.5 Regulatory Framework
      • 7.2.3.6 Reimbursement Scenario
  • 7.3 Europe
    • 7.3.1 Europe, SWOT Analysis
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 Key Country Dynamics
      • 7.3.2.3 Target Disease Prevalence
      • 7.3.2.4 Competitive Scenario
      • 7.3.2.5 Regulatory Framework
      • 7.3.2.6 Reimbursement Scenario
    • 7.3.3 Germany
      • 7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Key Country Dynamics
      • 7.3.3.3 Target Disease Prevalence
      • 7.3.3.4 Competitive Scenario
      • 7.3.3.5 Regulatory Framework
      • 7.3.3.6 Reimbursement Scenario
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Key Country Dynamics
      • 7.3.4.3 Target Disease Prevalence
      • 7.3.4.4 Competitive Scenario
      • 7.3.4.5 Regulatory Framework
      • 7.3.4.6 Reimbursement Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 Key Country Dynamics
      • 7.3.5.3 Target Disease Prevalence
      • 7.3.5.4 Competitive Scenario
      • 7.3.5.5 Regulatory Framework
      • 7.3.5.6 Reimbursement Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.6.2 Key Country Dynamics
      • 7.3.6.3 Target Disease Prevalence
      • 7.3.6.4 Competitive Scenario
      • 7.3.6.5 Regulatory Framework
      • 7.3.6.6 Reimbursement Scenario
    • 7.3.7 Sweden
      • 7.3.7.1 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.7.2 Key Country Dynamics
      • 7.3.7.3 Target Disease Prevalence
      • 7.3.7.4 Competitive Scenario
      • 7.3.7.5 Regulatory Framework
      • 7.3.7.6 Reimbursement Scenario
    • 7.3.8 Denmark
      • 7.3.8.1 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.8.2 Key Country Dynamics
      • 7.3.8.3 Target Disease Prevalence
      • 7.3.8.4 Competitive Scenario
      • 7.3.8.5 Regulatory Framework
      • 7.3.8.6 Reimbursement Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.3.9.2 Key Country Dynamics
      • 7.3.9.3 Target Disease Prevalence
      • 7.3.9.4 Competitive Scenario
      • 7.3.9.5 Regulatory Framework
      • 7.3.9.6 Reimbursement Scenario
    • 7.3.10 Rest Of Europe
      • 7.3.10.1 Rest Of Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific, SWOT Analysis
    • 7.4.2 India
      • 7.4.2.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.2.2 Key Country Dynamics
      • 7.4.2.3 Target Disease Prevalence
      • 7.4.2.4 Competitive Scenario
      • 7.4.2.5 Regulatory Framework
      • 7.4.2.6 Reimbursement Scenario
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.3.2 Key Country Dynamics
      • 7.4.3.3 Target Disease Prevalence
      • 7.4.3.4 Competitive Scenario
      • 7.4.3.5 Regulatory Framework
      • 7.4.3.6 Reimbursement Scenario
    • 7.4.4 Japan
      • 7.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.4.2 Key Country Dynamics
      • 7.4.4.3 Target Disease Prevalence
      • 7.4.4.4 Competitive Scenario
      • 7.4.4.5 Regulatory Framework
      • 7.4.4.6 Reimbursement Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.5.2 Key Country Dynamics
      • 7.4.5.3 Target Disease Prevalence
      • 7.4.5.4 Competitive Scenario
      • 7.4.5.5 Regulatory Framework
      • 7.4.5.6 Reimbursement Scenario
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.6.2 Key Country Dynamics
      • 7.4.6.3 Target Disease Prevalence
      • 7.4.6.4 Competitive Scenario
      • 7.4.6.5 Regulatory Framework
      • 7.4.6.6 Reimbursement Scenario
    • 7.4.7 THAILAND
      • 7.4.7.1 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.7.2 Key Country Dynamics
      • 7.4.7.3 Target Disease Prevalence
      • 7.4.7.4 Competitive Scenario
      • 7.4.7.5 Regulatory Framework
      • 7.4.7.6 Reimbursement Scenario
    • 7.4.8 Rest Of APAC
      • 7.4.8.1 Rest Of APAC Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America, SWOT Analysis
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.2.2 Key Country Dynamics
      • 7.5.2.3 Target Disease Prevalence
      • 7.5.2.4 Competitive Scenario
      • 7.5.2.5 Regulatory Framework
      • 7.5.2.6 Reimbursement Scenario
    • 7.5.3 Brazil
      • 7.5.3.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.3.2 Key Country Dynamics
      • 7.5.3.3 Target Disease Prevalence
      • 7.5.3.4 Competitive Scenario
      • 7.5.3.5 Regulatory Framework
      • 7.5.3.6 Reimbursement Scenario
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.5.4.2 Key Country Dynamics
      • 7.5.4.3 Target Disease Prevalence
      • 7.5.4.4 Competitive Scenario
      • 7.5.4.5 Regulatory Framework
      • 7.5.4.6 Reimbursement Scenario
    • 7.5.5 Rest Of LATAM
      • 7.5.5.1 Rest Of LATAM Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 Middle East & Africa, SWOT Analysis
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 Key Country Dynamics
      • 7.6.2.3 Target Disease Prevalence
      • 7.6.2.4 Competitive Scenario
      • 7.6.2.5 Regulatory Framework
      • 7.6.2.6 Reimbursement Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Key Country Dynamics
      • 7.6.3.3 Target Disease Prevalence
      • 7.6.3.4 Competitive Scenario
      • 7.6.3.5 Regulatory Framework
      • 7.6.3.6 Reimbursement Scenario
    • 7.6.4 UAE
      • 7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Key Country Dynamics
      • 7.6.4.3 Target Disease Prevalence
      • 7.6.4.4 Competitive Scenario
      • 7.6.4.5 Regulatory Framework
      • 7.6.4.6 Reimbursement Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 Key Country Dynamics
      • 7.6.5.3 Target Disease Prevalence
      • 7.6.5.4 Competitive Scenario
      • 7.6.5.5 Regulatory Framework
      • 7.6.5.6 Reimbursement Scenario
    • 7.6.6 Rest Of MEA
      • 7.6.6.1 Rest Of MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Public Companies
    • 8.1.1 Company Market Position Analysis
    • 8.1.2 Competitive Dashboard Analysis
    • 8.1.3 Strategic Framework
  • 8.2 Private Companies
    • 8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 8.2.2 Regional Network Map
  • 8.3 Company Profiles
    • 8.3.1 Varian Medical Systems, Inc. (A Part Of Siemens Healthineers)
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Elekta AB
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Accuray Incorporated
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Ion Beam Applications (IBA).
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 BD (Becton, Dickinson And Company)
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Isoray Medical
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 Mevion Medical Systems
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Product Benchmarking
      • 8.3.7.3 Strategic Initiatives
    • 8.3.8 Nordion Inc.
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Product Benchmarking
      • 8.3.8.3 Strategic Initiatives
    • 8.3.9 NTP Radioisotopes SOC Ltd.
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Curium
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Product Benchmarking
      • 8.3.10.3 Strategic Initiatives
    • 8.3.11 VIEWRAY TECHNOLOGIES, INC.
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Radiation Oncology Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 8 Global Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 U.K. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 U.K. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 U.K. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 France Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 France Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Italy Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Spain Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Spain Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Denmark Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Sweden Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Norway Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 46 Norway Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Japan Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 China Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 China Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 India Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 India Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Australia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Australia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Thailand Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Latin America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Brazil Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 Mexico Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Mexico Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Argentina Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 Argentina Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 South Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 90 South Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 South Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 UAE Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 UAE Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Radiation oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Radiation oncology market snapshot
  • Fig. 10 Radiation oncology market segmentation
  • Fig. 11 Radiation oncology market driver impact
  • Fig. 12 Radiation oncology market restraint impact
  • Fig. 13 Key market opportunities
  • Fig. 14 SWOT analysis, by factor (political & legal economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Radiation oncology market: Type outlook and key takeaways
  • Fig. 17 Radiation oncology market: Type movement analysis
  • Fig. 18 External beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Electron-emitting high energy linear accelerators market, 2018 - 2030 (USD Million)
  • Fig. 20 Compact advanced radiotherapy systems market, 2018 - 2030 (USD Million)
  • Fig. 21 CyberKnife market, 2018 - 2030 (USD Million)
  • Fig. 22 Gamma Knife market, 2018 - 2030 (USD Million)
  • Fig. 23 Tomotherapy market, 2018 - 2030 (USD Million)
  • Fig. 24 Proton therapy market, 2018 - 2030 (USD Million)
  • Fig. 25 Cyclotron market, 2018 - 2030 (USD Million)
  • Fig. 26 Synchrotron market, 2018 - 2030 (USD Million)
  • Fig. 27 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 28 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Seeds market, 2018 - 2030 (USD Million)
  • Fig. 30 Applicators and after-loaders market, 2018 - 2030 (USD Million)
  • Fig. 31 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 32 Systemic beam radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2016-2028 (USD Million)
  • Fig. 34 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology outlook and key takeaways
  • Fig. 35 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology movement analysis
  • Fig. 36 Radiation oncology market: Internal Beam Radiation Therapy (IBRT) technology movement analysis
  • Fig. 37 EBRT market, 2018 - 2030 (USD Million)
  • Fig. 38 IGRT market, 2018 - 2030 (USD Million)
  • Fig. 39 IMRT market, 2018 - 2030 (USD Million)
  • Fig. 40 Stereotactic radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 41 Proton beam therapy market, 2018 - 2030 (USD Million)
  • Fig. 42 3D-CRT market, 2018 - 2030 (USD Million)
  • Fig. 43 VMAT market, 2018 - 2030 (USD Million)
  • Fig. 44 Brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 45 LDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 HDR brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Radiation oncology market: Application outlook and key takeaways
  • Fig. 48 Radiation oncology market: EBRT Application movement analysis
  • Fig. 49 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 50 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 51 Lung cancer market, 2018 - 2030 (USD Million)
  • Fig. 52 Head and neck cancer market, 2018 - 2030 (USD Million)
  • Fig. 53 Colorectal cancer market, 2018 - 2030 (USD Million)
  • Fig. 54 Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 56 Gynecologic cancer market, 2018 - 2030 (USD Million)
  • Fig. 57 Breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 58 Cervical cancer market, 2018 - 2030 (USD Million)
  • Fig. 59 Penile cancer market, 2018 - 2030 (USD Million)
  • Fig. 60 Others market, 2018 - 2030 (USD Million)
  • Fig. 61 Radiation Oncology market: Regional outlook and key takeaways
  • Fig. 62 Radiation Oncology Market: Regional Movement Analysis
  • Fig. 63 North America
  • Fig. 64 North America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 65 U.S.
  • Fig. 66 U.S. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 67 Canada
  • Fig. 68 Canada radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 69 Europe
  • Fig. 70 Europe radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 71 Germany
  • Fig. 72 Germany radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 73 U.K.
  • Fig. 74 U.K. radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 75 France
  • Fig. 76 France radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 77 Italy
  • Fig. 78 Italy radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 79 Spain
  • Fig. 80 Spain radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 81 Denmark
  • Fig. 82 Denmark radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Sweden
  • Fig. 84 Sweden radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Norway
  • Fig. 86 Norway radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Rest of Europe
  • Fig. 88 Rest of Europe radiation oncology Market, 2018 - 2030 (USD Million
  • Fig. 89 Asia Pacific
  • Fig. 90 Asia Pacific radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 91 Japan
  • Fig. 92 Japan radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 93 China
  • Fig. 94 China radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 95 India
  • Fig. 96 India radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 97 South Korea
  • Fig. 98 South Korea radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 99 Australia
  • Fig. 100 Australia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 101 Thailand
  • Fig. 102 Thailand radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 103 Rest of APAC
  • Fig. 104 Rest of APAC radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 105 Latin America
  • Fig. 106 Latin America radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 107 Brazil
  • Fig. 108 Brazil radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 109 Mexico
  • Fig. 110 Mexico radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 111 Argentina
  • Fig. 112 Argentina radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 113 Rest of LATAM
  • Fig. 114 Rest of LATAM radiation oncology Market, 2018 - 2030 (USD Million)
  • Fig. 115 Middle East & Africa
  • Fig. 116 Middle East and Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 117 South Africa
  • Fig. 118 South Africa radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 119 Saudi Arabia
  • Fig. 120 Saudi Arabia radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 121 UAE
  • Fig. 122 UAE radiation oncology market estimates and forecast, 2018 - 2030
  • Fig. 123 Kuwait
  • Fig. 124 Kuwait radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Rest of MEA
  • Fig. 126 Rest of MEA radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Company market share analysis
  • Fig. 128 Company market position analysis (Total revenue)
  • Fig. 129 Company market position analysis (Profit margin)
  • Fig. 130 Competitive dashboard analysis
  • Fig. 131 Regional Network Map
  • Fig. 132 Strategic Framework